Sudeep Pharma lists with sharp premium over issue price

Sudeep Pharma listed about 24% above its issue price after its ₹895 crore IPO was subscribed nearly 94 times.

positive
Recently

Sudeep Pharma lists with sharp premium over issue price

1 min read51 words
Sudeep Pharma lists with sharp premium over issue price
Sudeep Pharma listed about 24% above its issue price after its ₹895 crore IPO was subscribed nearly 94 times.
Sudeep Pharma debuted at a 24% premium to its issue price of ₹593, opening near ₹774. The IPO raised ₹895 crore and saw strong demand with subscription reaching nearly 94 times. Early trading recorded firm volumes as investors assessed listing strength and the company’s growth outlook within the pharma sector.
Sentinel